Statistics

Total Visits

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database94

Select a period of time:

Number of views in the range

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database30

Views

Views
December 20252
January 202612
February 20260
March 20265
April 20260
May 20265
June 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
Finland6
Netherlands4
Argentina1
Colombia1
Ethiopia1
United Kingdom1
Mexico1
Tunisia1
 

Top cities views

Views
Helsinki5
Groningen4
Los Angeles3
Council Bluffs2
Addis Ababa1
Celaya1
Fair Oaks1
Kansas City1
Mar del Plata1
Montería1